CDSCO UID IMP/IVD/2021/000081_6ddbebfebe42a5962073958b958503bd_2e12329cdd74679d6316310c34e5226c

H30 Pro Hematology Analyzer

BIOLINE DIAGNOSTICS LLP·Device Class Class A·India CDSCO·Brand: Edan
Registration details
UID
IMP/IVD/2021/000081_6ddbebfebe42a5962073958b958503bd_2e12329cdd74679d6316310c34e5226c
Device class
Class A
Brand name
Edan
Approving authority
CDSCO
Product information
The H30 Pro Hematology Analyzer is intended to measure and calculate hematological parameters in whole blood samples.
Similar products (3)
Other products with the same name or brand
Test Cartridge
Brand: Edan
NISHA SALES
Class C
Controls
Brand: Edan
NISHA SALES
Class C
Calibrant Fluid Pack
Brand: Edan
NISHA SALES
Class C
Other products from BIOLINE DIAGNOSTICS LLP
Products from the same license holder (10 products)
Typhoid Antigen Rapid Test Device
Brand: CRP
Class C
Malaria Pf/PAN Antigen Rapid Test Device
Brand: CRP
Class C
Troponin I Rapid Test Device
Brand: CRP
Class C
Syphilis Rapid Test Device
Brand: First View
Class D
Dengue IgG/IgM & NS1 Antigen Combo Rapid Test Device
Brand: CRP
Class C
C- Reactive Protein Turbidimetric Test Kit
Brand: CRP
Class C
Dengue NS1 Antigen Rapid Test Device
Brand: CRP
Class C
C- Reactive Protein Latex Kit
Brand: CRP
Class C
Malaria Pf/Pv Antigen Rapid Test Device
Brand: CRP
Class C
HIV 1/2 Rapid Test Device
Brand: First View
Class D
About this record

H30 Pro Hematology Analyzer is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2021/000081_6ddbebfebe42a5962073958b958503bd_2e12329cdd74679d6316310c34e5226c. This device is marketed under the brand name Edan. The license holder is BIOLINE DIAGNOSTICS LLP, and it is classified as Device Class Class A. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.